Skip to main content

Table 2 Proportion of women with viral load ≥400 copies/mL, immunologic failure and self-report on drug adherence in Mitra Plus women on ART for life

From: Virologic and immunologic failure, drug resistance and mortality during the first 24 months postpartum among HIV-infected women initiated on antiretroviral therapy for life in the Mitra plus Study, Dar es Salaam, Tanzania

Time point

Number with viral load ≥ 400 copies/ml/number tested (%)

Number with immunologic failure/number tested (%)

Drug adherence; Number adhering/number tested (%)

Enrolment

71/73 (97%)

-

 

Month 3

11/67 (16%)

-

64/68 (95%)

Month 6

15/69 (22%)

8/69 (12%)

56/66 (85%)

Month 12

36/59 (61%)

15/60 (25%)

39/53 (74%)

Month 24

48/56 (86%)

24/58 (41%)

30/46 (65%)